News
Hosted on MSN8mon
Lexicon to cut 50% of workforce to focus on sotagliflozinLexicon Pharmaceuticals (NASDAQ:LXRX) plans to cut around 50% of its workforce, or more than 75 jobs, to prioritize commercialization of its drug sotagliflozin, also known as Inpefa and Zynquista.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback